Compare Vaxcyte Inc. Common Stock (PCVX) vs Riot Platforms Inc (RIOT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Vaxcyte Inc. Common Stock vs Riot Platforms Inc — how do they compare? Vaxcyte Inc. Common Stock trades at $67.37 (market cap $10.51B), while Riot Platforms Inc trades at $14.68 (market cap $6.26B). The key difference: Vaxcyte Inc. Common Stock is the larger of the two by market cap, and Vaxcyte Inc. Common Stock is trading nearer its 52-week high, Riot Platforms Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Vaxcyte Inc. Common Stock for 0 Days and Riot Platforms Inc for 16 Days on average.
| PCVX | RIOT | |
|---|---|---|
Market Cap | $10.51B | $6.26B |
Volume | 2,644,694 | 19,608,398 |
Sector | Health | Financials |
52-Week High | $73.82 | $28.67 |
52-Week Low | $40.32 | $11.83 |
Typical Hold Time | 0 Days | 16 Days |
Enterprise Value | $9.14B | $6.66B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
RIOT Platforms trades at $16.67, up 1.21% with a bearish technical signal despite bullish oscillators. The company reported significant losses with a net income margin of -196.28% and negative cash flow from operations of -$573 million in 2025. Recent strategic shift to data center leasing secured $9.8 billion in contracted revenue through 2048, attracting major tenants like AMD.
Analyst consensus remains strongly bullish with 94.74% buy ratings and a $31.64 price target, suggesting substantial upside potential. Key risks include persistent negative profitability, high valuation multiples, and execution challenges in the AI infrastructure transition. The stock faces near-term pressure from consecutive earnings misses but offers long-term growth potential through its power capacity assets.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Vaxcyte Inc. Common Stock
Vaxcyte, Inc. is a clinical-stage vaccine company that engineers protein-based vaccines to prevent bacterial diseases such as invasive pneumococcal disease, using its proprietary cell-free protein synthesis platform to develop candidates including the pneumococcal conjugate vaccines VAX-31 and VAX-24.
Read more on PCVX →About Riot Platforms Inc
Riot Platforms, Inc. is a Bitcoin mining company that focuses on building, operating, and expanding large-scale infrastructure for digital asset mining in North America. The company's operations include Bitcoin mining, data center hosting, and engineering solutions. Riot's strategy emphasizes vertical integration to maximize efficiency and scale its mining capacity, aiming to be a leader in the global Bitcoin and digital infrastructure industry.
Read more on RIOT →
